Switzerland
# |
Name |
EPS (Diluted) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 54.35
|
Dec. 31, 2023 | USD 559.15 | -0.33% |
|
Switzerland |
|
2 |
USD 19.89
|
Dec. 31, 2023 | USD 185.09 | 3.05% |
|
Switzerland |
|
3 |
USD 16.98
|
Dec. 31, 2023 | USD 338.36 | -2.06% |
|
Switzerland |
|
4 |
USD 11.14
|
March 31, 2024 | USD 338.69 | -1.14% |
|
Switzerland |
|
5 |
USD 9.82
|
Dec. 31, 2024 | USD 677.38 | -0.33% |
|
Switzerland |
|
6 |
USD 8.37
|
Dec. 31, 2023 | USD 22.23 | -0.03% |
|
Switzerland |
|
7 |
USD 7.49
|
Dec. 31, 2023 | USD 164.65 | -0.33% |
|
Switzerland |
|
8 |
USD 7.29
|
Dec. 31, 2023 | USD 88.18 | 0.68% |
|
Switzerland |
|
9 |
USD 7.12
|
March 31, 2024 | USD 195.48 | -0.78% |
|
Switzerland |
|
10 |
USD 6.36
|
March 31, 2024 | USD 407.20 | 2.16% |
|
Switzerland |
|
11 |
USD 5.89
|
Dec. 31, 2024 | USD 107.97 | -1.21% |
|
Switzerland |
|
12 |
USD 3.33
|
Dec. 31, 2023 | USD 78.24 | 0.09% |
|
Switzerland |
|
13 |
USD 1.96
|
Dec. 31, 2023 | USD 92.36 | -0.62% |
|
Switzerland |
|
14 |
USD 0.75
|
Dec. 31, 2023 | USD 46.15 | 1.47% |
|
Switzerland |
|
15 |
USD 0.06
|
Dec. 31, 2023 | USD 75.92 | 0.25% |
|
Switzerland |
|
16 |
USD -2.24
|
Dec. 31, 2023 | USD 4.93 | -1.22% |
|
Switzerland |
|
17 |
USD -3.53
|
Dec. 31, 2023 | USD 22.91 | 2.51% |
|
Switzerland |
|
18 |
USD -9.15
|
Dec. 31, 2023 | USD 25.42 | 0.54% |
|
Switzerland |
The Eyewear company in Switzerland with the highest EPS (Diluted) is Vaudoise Assurances Holding SA (Swiss Stock Exchange: VAHN.SW) at USD 54.35.
The Eyewear company in Switzerland with the lowest EPS (Diluted) is CALIDA Holding AG (Swiss Stock Exchange: CALN.SW) at USD -9.15.
The top 10 Eyewear companies in Switzerland by EPS (Diluted) are Vaudoise Assurances Holding SA, The Swatch Group AG, Roche Holding AG, Sonova Holding AG, Lonza Group AG, DocMorris AG, IVF Hartmann Holding AG, Orell Füssli AG, Compagnie Financière Richemont SA and Ypsomed Holding AG.
The bottom 10 Eyewear companies in Switzerland by EPS (Diluted) are CALIDA Holding AG, Oculis Holding AG, Molecular Partners AG, Medartis Holding AG, Avolta AG, Alcon Inc., DKSH Holding AG, Novartis AG, Ypsomed Holding AG and Compagnie Financière Richemont SA.